Advancements in Composite Drug Delivery Systems for Osteosarcoma Treatment: Targeting ROS, Cuproptosis, and Mitochondrial Dysfunction
Drug Design, Development and Therapy · 2026-11 · Volume 20 · 1-17
DOI: 10.2147/dddt.s623715 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-11. Verfasst von Jiwei Huang und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Huang, J., Li, Q., Zhang, T., Xie, A., Feng, L., Zheng, Y., & Zhao, L. (2026). Advancements in Composite Drug Delivery Systems for Osteosarcoma Treatment: Targeting ROS, Cuproptosis, and Mitochondrial Dysfunction. Drug Design, Development and Therapy, Volume 20, 1-17. https://doi.org/10.2147/dddt.s623715
Vancouver
Huang J, Li Q, Zhang T, Xie A, Feng L, Zheng Y, et al. Advancements in Composite Drug Delivery Systems for Osteosarcoma Treatment: Targeting ROS, Cuproptosis, and Mitochondrial Dysfunction. Drug Design, Development and Therapy. 2026;Volume 20:1-17. doi:10.2147/dddt.s623715
BibTeX
@article{Huang2026,
author = {Huang, Jiwei and Li, Qiangqiang and Zhang, Tianyi and Xie, Aixia and Feng, Li and Zheng, Yukun and Zhao, Long},
title = {Advancements in Composite Drug Delivery Systems for Osteosarcoma Treatment: Targeting ROS, Cuproptosis, and Mitochondrial Dysfunction},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--17},
doi = {10.2147/dddt.s623715}
}
EUVIMED